Disease | multiple endocrine neoplasia type 1 |
Comorbidity | C0011854|type 1 diabetes mellitus |
Sentences | 2 |
PubMedID- 19703761 | Background and aims: once-daily (od) basal insulin glargine (gla) can be used as part of a multiple daily injection regimen in patients with type 1 diabetes mellitus. |
PubMedID- 25143741 | Idegasp provides similar, noninferior glycemic control to a standard basal-bolus regimen in patients with type 1 diabetes mellitus, with additional benefits of significantly lower episodes of hypoglycemia (particularly nocturnal) and fewer daily insulin injections. |
Page: 1